1.gif (1892 bytes)

Case Reports

Indian Pediatrics 2003; 40:415-418 

Preserved Umbilical Cord Facilitates Antenatal Diagnosis of Spinal Muscular Atrophy


Madhulika Kabra
Sadhna Arora
Arti Maria
Rajiv Aggarwal

From the Divisions of Genetics and Neonatology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110 029, India.

Correspondence to: Dr. Madhulika Kabra, Associate Professor, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110 029.
E-mail: [email protected]

Manuscript received: July 8, 2002; Initial review completed: August 13, 2002; Revision accepted: December 23, 2002

Spinal Muscular atrophy (SMA) Type I is a fatal autosomal recessive disease caused by homozygous deletion of telometric region of exon 7/8 of the SMN gene. Prenatal diagnosis is feasible and desirable by most families. We report on prenatal diagnosis of SMAI in a family where dried umbilical cord stump from the deceased affected baby was used to confirm the diagnosis. Prenatal diagnosis was provided in the subsequent pregnancy. We emphasize the need for storing DNA from individuals affected with suspected single gene disorders.

Key words: Prenatal diagnosis, spinal muscular atrophy Type I.

Extraction of DNA from old forensic specimens for genetic analysis is a known technique and has found wide application in forensic medicine and pathological investiga-tions(1,2). We would like to highlight an interesting case where it was possible to retrieve DNA from umbilical cord of a baby who died of suspected spinal muscular atrophy (SMA) 2 years ago. Retrieval of DNA was helpful in prenatal diagnosis of SMA in subsequent pregnancy.

Case Report

A 33-year-old 4th gravida mother, resident of Uttar Pradesh, with no previous live issue, was referred to us early in the 2nd trimester for antenatal dianosis of a possible neuromuscular disorder. Her first pregnancy had resulted in a spontaneous abortion. Both her subsequent pregnancies had resulted in the birth of floppy infants with neuromuscular weakness. The babies had difficulty in feeding and breathing, and died in infancy. Both the infants were treated at a local hospital and no definite diagnosis was avail-able as no neurophysiological/pathological studies were done, however clinical picture described by parents was suggestive of a neuromuscular disorder with a strong possibility of SMA type I. Parents were keen to have a healthy baby which was possible only by prenatal testing. Since genetic testing was not performed on the previous babies, no DNA from affected children was available for the exclusion of SMA in this pregnancy. However, due to an age-old custom, the umbilical cord of the last sibling was still available. In certain parts of rural India, the fallen off umbilical stump is tied by the bedside for the first 6 weeks and later sacredly buried among the roots of a Banyan/Bamboo tree. In their anxiety for the last sibling, the parents had forgotten to bury the cord and it still hung by the bedside even after two years. We thought of trying to retrieve DNA from the old cord. The parents were able to get the dried remains of the cord from which DNA was extracted successfully. The cord was cut in thin pieces and washed with Tris EDTA (TE) in 1.5 mL eppendrof tube. 500 µL of TE, 40 µL of 20% SDS and 10 µL of proteinase K (200 µL/mL) was added and kept at 65ºC for 2 hrs. After this 10µL of proteinase K was added again, mixture was vortexed and kept at 37ºC for 48 hrs. The mixture was then microcentrifuged for 5 minutes at 5000 rpm at room temperature. DNA extraction was done using the standard phenol chloroform extraction method twice(3). 3 M sodium acetate and ethanol were added mixed by inversion twice and microcentrifuged for 5 minutes and supernatant was recouped. The pallet was washed with 70% ethanol, dried and resuspended in distilled water and used for polymerase chain reaction (PCR).

The PCR method and conditions used for amplifying exon 7 and 8 of SMN genes used were as described by Shuan-Peilin(4). The PCR products were digested by restriction enzyme Dra 1 and Dde 1 for exon 7 and exon 8 respectively and then electrophoresed on 3.5% agarose gel.

On evaluation parents showed two fragments of exon 7 after Dra 1 digestion whereas in umbilical cord DNA (i.e., affected child’s) telomeric copy was deleted (Fig. 1). This confirmed the diagnosis of SMA in the previous child. CVS DNA had an intact telomeric copy whereas centromeric copy was deleted. Similarly, exon 8 telomeric deletion was found in the cord DNA whereas CVS DNA did not show telomeric deletion (Fig.1). Parents were counseled and they decided to continue with the pregnancy. A healthy term female baby was born. She is in regular follow up and is asymptomatic at 6 months of age. The test was repeated postnatally and it matched with the CVS results.


Fig. 1. Analysis of SMN exon 07 (lane 2-7) and 8 (lane 8-13). Lane 1: 100 bp ladder; Lane 2: +ve control for exon 7 telomeric deletion; Lane 3: mother; Lane 4: father; Lane 5: CVS (+ve for centromeric deletion); Lane 6: umbilical cord DNA (+ve for telomeric deletion); Lane 7: baby at the age of 3 months (+ve for centromeric deletion); Lane 8: –ve control for exon t; Lane 9: mother; Lane 10: father; Lane 11: CVS (+ve for centromeric deletion); Lane 12: umbilical cord DNA (+ve for telomeric deletion); Lane 13: baby at the age of 3 months (+ve for centromeric deletion).

Discussion

The gene for SMA (all three types) has been mapped to chromosome 5q13(5). Out of two candidate genes, i.e., survival motor neuron gene (SMN) and neuronal apoptosis inhibitory gene (NAIP), SMN gene has been implicated more commonly as the causative gene. According to Western literature in about 95-98% of SMA I patients there is homozygous deletion of the telomeric copy exon 7 of SMN gene(6). Isolated homo-zygous deletion of the centromeric copy does not lead to symptoms, though recently a case report from India has described one such SMA case(7). Homozygous centrometric deletion has been reported in normal asymptomatic individuals also(6). Presence of centromeric deletion in addition to telo-meric deletion/point mutation can probably contribute to severity of disease. In the present family parents were counseled about all these aspects and they decided to continue with the pegnancy.

Literature review has shown that DNA extraction is possible even years later from postmortem tissue. DNA has been extracted and purified from various forensic specimens(2,8). DNA material has been extracted successfully from specimens even after prolonged periods ranging from a few weeks to many months. Some studies have shown that there is no correlation between the age of the specimen and the extent of DNA preservation(2). Specific gene fragments can be amplified for sequencing or fingerprinting. This has found wide applications in the field of forensic medicine but rearely in clinical set-up. In our case it was possible to extract DNA from an old umblical cord. Genetic studies for SMA from this DNA were helpful in the antenatal diagnosis and genetic counseling.

As the DNA testing of affected individual is crucial for diagnosis and prenatal diagnosis of single gene disorders, it is advisable that the physicians taking care of children with suspected genetic disorder save blood for DNA extraction. Non-availability of the DNA can be extremely problematic as exemplified by the difficulties encountered in this case.

Contributors: SA did the molecular studies. MK was involved in prenatal and postnatal counselling and preparation of the manuscript and will act as a guarantor of the manuscript. AM and RA were involved in the evaluation of the baby after birth and preparation of the manuscript.

Funding: None.

Competing interests: None stated.

 

 References


1. Phang TW, Shi CY, Chia JN, Ong CN. Amplification of cDNA via RT-PCR using RNA extracted from post mortem tissues. J Forensic Sci 1994; 39: 1275-1279.

2. Evison MP, Smithe DM, Chamberlain AT. Extraction of single-copy nuclear DNA from forensic specimens with a variety of postmortem histories. J Forensic Sci 1997; 42: 1032-1038.

3. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith J, et al. Current Protocols in Molecular Biology. New York: Greene Publishing Associates and Wiley Interscience 1992; 1: 2.1.1 - 2.1.7.

4. Shuan-Pei L, Chang JG, Jong YJ, Yang TY, Tsai CH, Wang NM et al. Parental prediction of spinal muscular atrophy in Chinese. Prenat Diagn 1999; 19: 657-661.

5. Lefebvre S, Burglen L, Rehoullet S, Olivier C, Burlet P, Viollet L et al. Identification and characterization of a spinal muscular atrophy - determining gene. Cell 1995; 80: 155-165.

6. Somerville MJ, Hunder AGW, Koreneluk ARG, Mackenzie AE, Surh LC. Clinical application of the molecular diagnosis of spinal muscular atrophy: Deletions of neuronal apoptosis inhibitor protein and survival motor neuron genes. Am J Med Genet 1997; 69: 159-165.

7. Srivastava S, Kukherjee M, Panigrahi I, Pandey SG, Pradhan NA, Mittal B. SN2- deletion in childhood-onset spinal muscular atrophy. Am J Med Genet 2001; 101: 198-202.

8. Higuchi R, von Beroldingen CH, Sensabaugh GF, Erlich HA. DNA typing from single hair. Nature 1988; 331: 543-546.

Home

Past Issue

About IP

About IAP

Feedback

Links

 Author Info.

  Subscription